This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Council of Scientific and Industrial Research. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Amlanjyoti Dhar: Innovator in Cancer Research
Introduction
Amlanjyoti Dhar is a notable inventor based in Kolkata, India. He has made significant contributions to the field of cancer research through his innovative work on peptides. His research focuses on developing effective treatments for cancers that over-express specific proteins.
Latest Patents
Amlanjyoti Dhar holds a patent for a "High affinity bivalent helically constrained peptide against cancer." This invention describes a novel bivalent helically constrained peptide targeted against S100B, which is an effective anti-cancer drug. The peptide induces rapid apoptosis in cancer cells that over-express the calcium-binding protein S100B. It achieves this through the simultaneous inhibition of key growth pathways, including the activation of p53.
Career Highlights
Amlanjyoti Dhar is associated with the Council of Scientific and Industrial Research, where he continues to advance his research in cancer therapeutics. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from cancers linked to S100B over-expression.
Collaborations
Some of his notable coworkers include Shampa Mallick and Israr Ahmed, who have collaborated with him on various research projects.
Conclusion
Amlanjyoti Dhar's innovative work in developing targeted cancer therapies highlights his commitment to advancing medical science. His contributions are paving the way for new treatment options in oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile